These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 32360846)

  • 1. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
    Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
    Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
    Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
    Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
    Mandelbaum RS; Matsuzaki S; Sangara RN; Klar M; Matsushima K; Roman LD; Paulson RJ; Wright JD; Matsuo K
    Am J Obstet Gynecol; 2021 Oct; 225(4):399.e1-399.e32. PubMed ID: 34181896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.
    Karia PS; Huang Y; Tehranifar P; Visvanathan K; Wright JD; Genkinger JM
    Am J Obstet Gynecol; 2022 Aug; 227(2):257.e1-257.e22. PubMed ID: 35489439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
    Hanley GE; McAlpine JN; Pearce CL; Miller D
    Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
    Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
    Salvador S; Scott S; Francis JA; Agrawal A; Giede C
    J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
    Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
    Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
    Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
    Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake and Predictors of Opportunistic Salpingectomy for Ovarian Cancer Risk Reduction in the United States.
    Karia PS; Joshu CE; Visvanathan K
    Cancer Prev Res (Phila); 2021 Dec; 14(12):1101-1110. PubMed ID: 34413116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
    Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: A survey of current Australian practice.
    Kapurubandara S; Qin V; Gurram D; Anpalagan A; Merkur H; Hogg R; Brand A
    Aust N Z J Obstet Gynaecol; 2015 Dec; 55(6):606-11. PubMed ID: 26768958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital Variation in the Practice of Bilateral Salpingectomy With Ovarian Conservation in 2012.
    Xu X; Desai VB
    Obstet Gynecol; 2016 Feb; 127(2):297-305. PubMed ID: 26942357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011.
    Mikhail E; Salemi JL; Mogos MF; Hart S; Salihu HM; Imudia AN
    Am J Obstet Gynecol; 2015 Nov; 213(5):713.e1-13. PubMed ID: 25935772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Opportunistic Salpingectomy at the Time of Benign Hysterectomy.
    Till SR; Kobernik EK; Kamdar NS; Edwards MG; As-Sanie S; Campbell DA; Morgan DM
    J Minim Invasive Gynecol; 2018 Jan; 25(1):53-61. PubMed ID: 28712794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
    Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Evolution of and Evidence for Opportunistic Salpingectomy.
    Dilley SE; Straughn JM; Leath CA
    Obstet Gynecol; 2017 Oct; 130(4):814-824. PubMed ID: 28885426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.
    van Lieshout LAM; Steenbeek MP; De Hullu JA; Vos MC; Houterman S; Wilkinson J; Piek JM
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012858. PubMed ID: 31456223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of salpingectomy at hysterectomy to reduce the risk of epithelial ovarian cancer: a systematic review.
    Darelius A; Lycke M; Kindblom JM; Kristjansdottir B; Sundfeldt K; Strandell A
    BJOG; 2017 May; 124(6):880-889. PubMed ID: 28190289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target?
    Kotsopoulos J; Narod SA
    Int J Cancer; 2020 Sep; 147(5):1245-1251. PubMed ID: 32037528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.